Amgn analise wyckoffon this entry we have a distribution phase now we see a support point which confirmed the testing of the climactic movementShort00:23by StudentWyckoff0
W PatternsAs a rule, when I see a crooked W, I steer clear and watch it if it is a security I want. The impulse/long leg/is to the downside whereas a bullish crooked M pattern, the impulse leg is up. We are all different. Crooked Ws are not always bearish, but it just gets too complicated for this post so I will stop there. For the most part, a W is bearish. I have noted a W will pull to the middle, or the hump, or point in the middle of the W. I marked it with a green X. Does this always happen? NO. Can it go further than this point or not as far? YES. Just a guide for me, and we are all different. Does the same exact thing happen twice in the market on a regular basis? NO LOL Often a Double Bottom will have a W associated with it. I often wait for price to come back to this point and reassess if I am not already in the security when I see it. You can do fib levels to figure out which bearish harmonic pattern the W represents if you wish to hang on to the last leg up of that W, then sell and catch it again when it hits another entry level. Ws are usually bearish but if you know your patterns, it is possible to go long on the last leg up of the W. No recommendation Tomorrow is another day (o:Educationby lauralea223
ABC BullishPossible stop under C. No recommendation. Short percent is 2.14%. Earnings due again on 5-18 BMO. W not so attractive but have noted that securities often pull to the middle hump of the W and this one is very close. With double bottoms often there is a W associated with the double bottom. Ws can be bearish. The tail of a red long legged doji candle did hit the 2nd leg of the W.Longby lauralea1
AMGN Long Term LongTop pharma pick right now other than BMY. P/E 13.11 with forecasted 6-7% earnings growth and an EPS yield of 7.62%. Historic Norm P/E 18.89 ^ 10 Y = 14.50 ^ 5 Y = 14.25 3.49% Div payer. Valuation estimate based on 2023 forecasted EPS (19.11) and P/E of 14.25 = $272.32Longby CG_Financial111
Bearish on Amgen. AMGNImmediate targets 211, 200,186. Invalidation at 279. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safeShortby Rykin_Capital0
AMGN ShortCommodity Channel Index (CCI) Jan 26 Daily Short-Term Bearish Volume 2,799,706 Close Price 222.54 Pattern Duration 1 day Triple Moving Average Crossover (4-day 9-day 18-day) Jan 27 Daily Short-Term Bearish Volume 2,492,054 Close Price 224.00 Pattern Duration 1 day Commodity Channel Index (CCI) Jan 27 Daily Other Volume 2,492,054 Close Price 224.00 Pattern Duration 1 dayShortby Skinnaah111
AMGN has a nice setupAMGN looks ready to rip. Bullish crossover on the Stochastic, Super Trend is green and price closed above the 200 EMA. Looking for $230+ this week. Longby chaseflores101
AMGN_Continue the correction processLocated close to dynamic resistance. Be careful on the BUY side. The RSI has also reached the buy saturation zone. BUY after breaking the dynamic resistance and stabilizing it high.by Behnam_Hosein_Nezhad0
Buy $AMGN - NRPicks 19 NovAmgen Inc. discovers, develops, manufactures and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It has agreements with Novartis, Bayer, among others. Revenue TTM 25.7B Net Income TTM 5.6B EBITDA TTM 12.1B EBITDA margin TTM 47.1%. Debt/EBITDA TTM 3.05xLongby NewroadTraderUpdated 2
$AMGN bouncing off MT support (4/5)Conviction: 4/5 there may be near-term pullback for better entry at support General Thesis bounce from medium-term resistance (2017) although a bit of indecision around resistance line Weekly RSI showing good bounce near historical support Growth Margins high but declined in 2021 growth is low but around 50th percentile compared to self Value P/FCF is high: about 80th percentile P/S is below average: about 35th percentile Fundamentals/Balance Sheet debt/asset ratio good: below 1 quick ratio good: above 1 Potential Risks expensive market... Longby asdf0981
AMGEN a safe buy?AMGEN INC seems to be a solid buy for a +30% move to the upside within 12 month. So not a super exciting play. But never the less I'll share it with you. We had a productive EWT a-b-c like movement to the downside as a correction. We have bounced on the multi year (since 2017) support trendline (green) and should see another test of the ATH within next 12 months. Stop loss at the green support. Or maybe a false break to test the fib 38.2? Anyway should be decent risk reeward in this trade.Longby Rationell0
$AMGN with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $AMGN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 60%. If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.Longby EPSMomentum0
Amgen Announces Positive Top-Line Results From Otezla® (apremilaAMGN: Amgen Inc. 2021-12-01 16:00:00 Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital PsoriasisLongby RocketTickers0
Buy $AMGN - NRPicks 10 SetAmgen Inc. discovers, develops, manufactures and delivers human therapeutics worldwide. It focuses on the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience. It has agreements with Novartis Pharma; Bayer HealthCar and Eli Lilly. Revenue TTM 25.4B Net Income TTM 5.7B EBITDA TTM 12.43B Net Margin TTM 22.5% Dividend yield 3.27%.Longby NewroadTraderUpdated 1
AMGN with nice setupHi Traders, AMGN fell after Q2 Earnings back in August and entered a downtrend down to ~200 USD. With this, it entered a strong area of support (ATH of 2018, low of Oct. 2020). AMGN then broke downward trend but then get capped by resistance at 210 USD and retestet downward trendline from above. By the end of October just before earnings it started to move up with significant increase in volume. This weeks retest of supportlevel at 210 USD was perfectly in line with fib levels. So by now the short term trend tends to be upwards, we have retestet trendline and support level and earnings behind us. Maybe ex-date can ruin this setup, but to be safe, an entry could also be done after passing last high at 219.26 USD. SL slighty under supportlevel of 210 USD. First target is trendline and maybe ATH. Cheers Longby chartsignale_san0
Technical analysis (AMGN)Amgen, Inc. (AMGN) Limit buy - 213,0$ Target - 243,05 Risk/Reward Ratio - 3,34 Stop-loss - 204,0 The price has approached a good level, we enter the position.Longby eroogar2
AMGEN who knows what they do, but it has to do with moneyInteresting compare to the crash off in money supply velocity to Amgen’s delayed bull run Maybe something to do with their business model. Also compares to money supply and seems to correlate with increase in money supply dollars finding their new homes as we can see as the money supply velocity drops off drastically. by TraderCaps1
AMGEN INC : CMP 206 AMGEN INC in Weekly Timeframe Correction from November 2019 l....this correction expected to end in 6 month....only buy after breakout which is above 230 on a weekly Closing basis....after Breakout Stock expected to run for target 400-485by PNW_INVESTMENTS1
AMGN: Short term sellAll trade in sell order/buy order, might not trigger, cancel if the price has run too far.Shortby UndergroundAnalyst0
FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 AMGN: Amgen 2021-09-25 20:00:00 FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial HypercholesterolemiaLongby RocketTickers0
GANN Theory Finally Completed StrategyI took a couple of months off to read a book i found on Amazon on Andrew Gann the inventor of GANN theory. After finishing his article i theorized that it could be transformed in these modern times. This will a Membership to perform, Alerts mean allot to people that want to automate the thought process behind this. Please note that i am not a paid person posting this, i been trading for 16 years ever since i graduated from High School, I went to college to understand Pattern Recognition. Believe it or not there is a pattern to every aspect of our Lives. I have the MTF Support and Resistance from Annan Set to Daily . Poor Mans Volume Profile ___ this is critical for plotting the GANN BOX onto the Charts with little to no thought process. To plot the GANN BOX (not the GANN fix Box or the GANN angles) You are taking the Gann Box Placing it on the Poor Mans Volume Profile DAILY chart. For an Uptrend you go UP 2 and right 2 , you'll understand when you plot it. For Down Trend down 2 right 2 . Sideways (rangebound) oddly special one. Up 1 Right 2 Down 1 Right 2 . When your plotting on the charts LOCK the Gann on the chart. I use Daily Right 2 because i set it at the beginning of the MONTH and its good for until the NEXT month. you set alerts on the GANN FIB LINES. (ENTRYS) BASED... If you are having issues with plotting this LET ME KNOW... its gets very automated when you plotting it. The Poor Mans Volume Profile takes the calculations out of the picture. Posting a picture of the Points your going up or down 2. How you Plot it on the Poor Mans Volume Profile. last step is to LOCK it on the Daily CHART. Alerts need to the be set on the 2 of the Gann Lines. ( set to Crossing ) Subscription premium allow you to set an unexpired alert. If you want to Swing with this strategy. You have to do something different by Anchoring on the Weekly and trading on the 30 min or 1hr you can swing with this. But as yourself are you going to swing or are you going to Day-trade this. Stop loss is a very touchie subject that everyone should think about doing... Personally i use 4 different methods Count 5 bars back, last Swing point, or Halfway between the two fibs of entry. if i am feeling lucky just on the other side of the Fib Entry point. * the Lucky part of this one is if it goes bad you have a very LOW LOW risk of loosing allot of hard earned capital. Generally I will use the 5 bars back method. CM- Slingshot set to Conservative. Next 2 will be the Exits on the Trades and Indicators to take the Trade. DYNAMIC RSI - DRSI for short just tweak the color on this one, from DreadBlitz. ____ MTF RSI from Chris Moody 14 70 30 D D 30 ___ set a color where you can see the MidPoint. NOTE: When Entering you are looking at the Chart___ when it crosses the GANN FIB line. after the Bar completes, look at the DRSI and MTF RSI midpoint cross. (after the Cross has Happen and you can Confirm it on both u can now Enter the Trade.) The exit point is when the DRSI goes Solid Filled color, secondly this effect will be happening on the MTF RSI. I take all of my trades on the 15min timeframe with an Anchor on the Daily Chart. Anchor meaning MTF MTF MTF MTF all of them are set to the daily. I want to make thoughtful readings based on the Daily Overall proceedings of the market direction. Editors' picksEducationby Mnbrass549Updated 2020138
Amgen: Short term up5th wave finished right at the major support, hoping for a jump if the support still valid. Previous batch of trades has closed except AMZN still running. (BABA-0.6%, UPS-1%, V-2%, AXP+1.5%, MAR+1.5%, SBUX+3%, WFC+0%)Longby UndergroundAnalyst1
AMGN LONG POSITIONNASDAQ:AMGN On a weekly timeframe chart, we can see that the candlesticks made a channel which have support line near 215 and the resistance near 260. We tasting support there.Longby insTRADER10